![](/img/cover-not-exists.png)
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
Punt, CJ, Voest, EE, Tueni, E, Van Oosterom, AT, Backx, A, De Mulder, PH, Hecquet, B, Lucas, C, Gerard, B, Bleiberg, HVolume:
76
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.1997.563
Date:
November, 1997
File:
PDF, 1.14 MB
english, 1997